Russell Gollard

632 total citations
30 papers, 450 citations indexed

About

Russell Gollard is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Russell Gollard has authored 30 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Russell Gollard's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Russell Gollard is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Russell Gollard collaborates with scholars based in United States. Russell Gollard's co-authors include Michael P. Kosty, Vincent Massullo, Hubert T. Greenway, Robert A. Weber, Scott Selco, Gerald M. Bordin, Robert A. Larsen, Para Chandrasoma, Lawrence D. Piro and Alan Saven and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Russell Gollard

28 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell Gollard United States 12 240 92 79 78 72 30 450
Burgess Ma United States 9 204 0.8× 58 0.6× 74 0.9× 77 1.0× 80 1.1× 17 387
Chris J Finch United States 5 404 1.7× 32 0.3× 55 0.7× 54 0.7× 39 0.5× 5 474
Sonia Bonanomi Italy 16 233 1.0× 73 0.8× 103 1.3× 56 0.7× 15 0.2× 45 820
F Kriaa France 14 181 0.8× 144 1.6× 26 0.3× 16 0.2× 10 0.1× 38 623
Manuel Abecasis Portugal 11 220 0.9× 230 2.5× 86 1.1× 21 0.3× 10 0.1× 24 865
S. T. S. Durrant United Kingdom 13 147 0.6× 89 1.0× 67 0.8× 15 0.2× 9 0.1× 25 381
Malek Aoudjhane France 6 135 0.6× 53 0.6× 64 0.8× 18 0.2× 11 0.2× 12 508
Makoto Mochizuki Japan 10 83 0.3× 59 0.6× 38 0.5× 14 0.2× 6 0.1× 46 384
Johnston Ww United States 13 136 0.6× 113 1.2× 34 0.4× 12 0.2× 11 0.2× 41 480
Gabriel C. Caponetti United States 10 114 0.5× 27 0.3× 25 0.3× 16 0.2× 11 0.2× 25 230

Countries citing papers authored by Russell Gollard

Since Specialization
Citations

This map shows the geographic impact of Russell Gollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Gollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Gollard more than expected).

Fields of papers citing papers by Russell Gollard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Gollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Gollard. The network helps show where Russell Gollard may publish in the future.

Co-authorship network of co-authors of Russell Gollard

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Gollard. A scholar is included among the top collaborators of Russell Gollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Gollard. Russell Gollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gollard, Russell. (2023). Factor X inhibitors: A seldom seen but important antibody mediated process. Haemophilia. 29(5). 1175–1175. 1 indexed citations
3.
Liu, Stephen V., et al.. (2012). Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab. Journal of Clinical Pharmacy and Therapeutics. 37(5). 607–609. 2 indexed citations
4.
Gollard, Russell. (2012). The Lusiad and “Isle of the Cross”. Leviathan. 14(3). 43–47.
5.
Gollard, Russell, et al.. (2012). Factor X Inhibitor: A Fulminant Presentation and Fatal Course of a Rare Syndrome in a 59-Year-Old Male. Acta Haematologica. 129(1). 40–44. 5 indexed citations
6.
Gollard, Russell, et al.. (2011). Intramedullary PNET of the Spine. Journal of Pediatric Hematology/Oncology. 33(2). 107–112. 11 indexed citations
7.
Hecht, J. Randolph, Madhavan V. Pillai, Russell Gollard, et al.. (2010). A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy. Clinical Colorectal Cancer. 9(2). 95–101. 50 indexed citations
8.
Gollard, Russell, et al.. (2010). Splenic non-Hodgkin's lymphoma without organomegaly: occult presentation with fatal course and post-mortem diagnosis. Rare Tumors. 2(1). 50–51. 1 indexed citations
9.
Gollard, Russell, et al.. (2010). Small Cell/Neuroendocrine Tumors of the Esophagus: Presentation of Two Cases and Review of the Literature. Tumori Journal. 96(5). 780–783. 12 indexed citations
10.
Gollard, Russell, et al.. (2010). Large cell/neuroendocrine carcinoma. Lung Cancer. 69(1). 13–18. 33 indexed citations
11.
Hecht, J. Randolph, et al.. (2009). Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase II, randomized, controlled study. Journal of Clinical Oncology. 27(15_suppl). 4072–4072. 3 indexed citations
12.
Gollard, Russell, William Wierda, & Jonathan C. Trent. (2007). Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor: Simultaneous Presentation. Journal of Clinical Oncology. 25(29). 4682–4683. 1 indexed citations
13.
Gollard, Russell, et al.. (2000). Merkel cell carcinoma. Cancer. 88(8). 1842–1851. 14 indexed citations
14.
Gollard, Russell, et al.. (2000). Merkel cell carcinoma. Cancer. 88(8). 1842–1851. 86 indexed citations
15.
Gollard, Russell, Bruce A. Robbins, Lawrence D. Piro, & Alan Saven. (1996). Acute Myelogenous Leukemia Presenting with Bulky Lymphadenopathy. Acta Haematologica. 95(2). 129–134. 8 indexed citations
16.
Gollard, Russell, et al.. (1996). Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue. Supportive Care in Cancer. 4(5). 364–369. 20 indexed citations
17.
Saven, Alan, Wing K. Cheung, Isabel Smith Zubiaga, et al.. (1996). Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.. Journal of Clinical Oncology. 14(3). 978–983. 37 indexed citations
18.
Gollard, Russell, et al.. (1995). Two Unusual Presentations of Müllerian Adenosarcoma: Case Reports, Literature Review, and Treatment Considerations. Gynecologic Oncology. 59(3). 412–422. 34 indexed citations
19.
Gollard, Russell, Thomas C. Lee, Lawrence D. Piro, & Alan Saven. (1995). The Optimal Management of Hairy Cell Leukaemia. Drugs. 49(6). 921–931. 8 indexed citations
20.
Gollard, Russell, HAROLD C. SLAVKIN, & Malcolm L. Snead. (1992). Polyoma virus-induced murine odontogenic tumors. Oral Surgery Oral Medicine Oral Pathology. 74(6). 761–767. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026